We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Wheaton Offers Unique Solutions for the Clinical Market

By LabMedica International staff writers
Posted on 29 Jul 2014
Print article
Wheaton (Millville, NJ, USA) provides high performance specialty containers to scientists and drug developers. The company is expanding its solutions-oriented product line to address the specific needs of the clinical laboratory. Clinical lab products that will be featured at AACC 2014 include vials specially designed for the cryopreservation of tissue samples, high precision chromatography vials, and vials eliminating 99% of residual waste for high value reagents.

CryoElite tissue vials are designed for the safe, secure, and effective cryopreservation of biological tissue specimens, which are essential for advances in biomedical research and have demanding requirements for cryogenic storage. They provide researchers and clinicians a uniform vial that maintains sample integrity while maximizing storage capacity and organization. They were developed for the high performance tissue banking requirements of anatomical pathology departments, clinical trial organizations, and biorepository and biobanking facilities.

MicroLiter chromatography vials are Class 10,000 clean room packed, making them a good choice for clinical Limit of Detection (LOD)/Limit of Quantitation (LOQ) assays, limited quantity specimens and unknown targets. They offer and high precision, versatility, and are easy-to-use. They were designed to the tightest tolerances to ensure that they exceed all autosampler specifications. The MicroLiter MPSS allows for robotic liquid handling with the “uLmat” that eliminates leakage and cross contamination between wells.

The line of high recovery vials has a special interior bottom design, allowing for maximum retrieval of contents and enabling more tests to be conducted from a single vial, providing greater resource efficiency for in vitro diagnostics and diagnostic kits. They are designed for manual or automated handling and storage, and are especially useful for high value reagents and samples, reducing product waste by 99% and enabling full product retrieval without the need to overfill.

Related Links:

Wheaton


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Auto 5-Part Differential Analyzer
XR-1000 Pure

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.